Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-129.27M
↓ 115% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-60.11M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-129.27M | -65.1% |
| 2024 | $-78.28M | -16.1% |
| 2022 | $-67.40M | -10.9% |
| 2021 | $-60.80M | +5.6% |
| 2020 | $-64.42M | -7.1% |
| 2019 | $-60.16M | -21.4% |
| 2018 | $-49.56M | -102.6% |
| 2017 | $-24.46M | -266.9% |
| 2016 | $-6.67M | - |